FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327724843> ?p ?o ?g. }

• W4327724843 abstract "Abstract Objectives Levosimendan as a calcium-sensitizer is a promising innovative therapeutical option for the treatment of severe cardiac dysfunction (CD) and pulmonary hypertension (PH) in preterm infants, but no data are available analyzing levosimendan in cohorts of preterm infants. Design/ Setting Retrospective single-center cohort study. Patients and Methods Retrospective single-center cohort study. Data of all preterm infants (gestational age (GA) <37 weeks) with levosimendan treatment and CD and/or PH in the echocardiographic assessment between 01/2018 and 06/2021 were screened for analysis. Main outcome measures The primary clinical endpoint was defined as echocardiographic response to levosimendan. Results 105 preterm infants were finally enrolled for further analysis. 48% of the preterm infants were classified as extremely low for GA newborns (ELGANs, <28 weeks of GA) and 73% as extremely low birth weight infants (<1500g, ELBW). The primary endpoint was reached in 71%, without difference regarding GA or BW. The incidence of moderate or severe PH decreased from baseline to follow-up (24h) in about 30%, with a significant decrease in the Responder-group (p<0.001). The incidence of left-ventricular dysfunction and bi-ventricular dysfunction decreased significantly from baseline to follow-up (24h) in the Responder-group (p=0.007, and p<0.001, respectively). The arterial lactate level decreased significantly from baseline (4.7 mmol/l) to 12h (3.6 mmol/l, p<0.05), and 24h (3.1 mmol/l, p<0.01). Conclusion Levosimendan treatment is associated with an improvement of both CD and PH in preterm infants, with a stabilization of the MAP during the treatment and a significant decrease of arterial lactate levels. Future prospective trials are highly warranted." @default.
• W4327724843 created "2023-03-18" @default.
• W4327724843 creator A5017132422 @default.
• W4327724843 creator A5019457969 @default.
• W4327724843 creator A5022064158 @default.
• W4327724843 creator A5042004934 @default.
• W4327724843 creator A5047983305 @default.
• W4327724843 creator A5048541901 @default.
• W4327724843 creator A5063760580 @default.
• W4327724843 creator A5076182753 @default.
• W4327724843 date "2023-03-17" @default.
• W4327724843 modified "2023-10-18" @default.
• W4327724843 title "Evaluation of levosimendan as treatment option in preterm infants with cardiac dysfunction and pulmonary hypertension" @default.
• W4327724843 cites W1967677604 @default.
• W4327724843 cites W1983477070 @default.
• W4327724843 cites W1993935135 @default.
• W4327724843 cites W2000876750 @default.
• W4327724843 cites W2002926363 @default.
• W4327724843 cites W2033225260 @default.
• W4327724843 cites W2046724909 @default.
• W4327724843 cites W2067317899 @default.
• W4327724843 cites W2077751664 @default.
• W4327724843 cites W2089707647 @default.
• W4327724843 cites W2113439927 @default.
• W4327724843 cites W2137041739 @default.
• W4327724843 cites W2139836388 @default.
• W4327724843 cites W2602461613 @default.
• W4327724843 cites W2613384048 @default.
• W4327724843 cites W2795722279 @default.
• W4327724843 cites W2879520505 @default.
• W4327724843 cites W2887926636 @default.
• W4327724843 cites W2963425674 @default.
• W4327724843 cites W3041121713 @default.
• W4327724843 cites W3049028489 @default.
• W4327724843 cites W3049091075 @default.
• W4327724843 cites W3129778906 @default.
• W4327724843 cites W3199926328 @default.
• W4327724843 cites W3205099924 @default.
• W4327724843 cites W4283745923 @default.
• W4327724843 cites W4292682937 @default.
• W4327724843 doi "https://doi.org/10.21203/rs.3.rs-2690790/v1" @default.
• W4327724843 hasPublicationYear "2023" @default.
• W4327724843 type Work @default.
• W4327724843 citedByCount "0" @default.
• W4327724843 crossrefType "posted-content" @default.
• W4327724843 hasAuthorship W4327724843A5017132422 @default.
• W4327724843 hasAuthorship W4327724843A5019457969 @default.
• W4327724843 hasAuthorship W4327724843A5022064158 @default.
• W4327724843 hasAuthorship W4327724843A5042004934 @default.
• W4327724843 hasAuthorship W4327724843A5047983305 @default.
• W4327724843 hasAuthorship W4327724843A5048541901 @default.
• W4327724843 hasAuthorship W4327724843A5063760580 @default.
• W4327724843 hasAuthorship W4327724843A5076182753 @default.
• W4327724843 hasBestOaLocation W43277248431 @default.
• W4327724843 hasConcept C120665830 @default.
• W4327724843 hasConcept C121332964 @default.
• W4327724843 hasConcept C126322002 @default.
• W4327724843 hasConcept C164705383 @default.
• W4327724843 hasConcept C167135981 @default.
• W4327724843 hasConcept C203092338 @default.
• W4327724843 hasConcept C2777335384 @default.
• W4327724843 hasConcept C2778198053 @default.
• W4327724843 hasConcept C2778376644 @default.
• W4327724843 hasConcept C2779234561 @default.
• W4327724843 hasConcept C2780930700 @default.
• W4327724843 hasConcept C535046627 @default.
• W4327724843 hasConcept C54355233 @default.
• W4327724843 hasConcept C61511704 @default.
• W4327724843 hasConcept C71924100 @default.
• W4327724843 hasConcept C72563966 @default.
• W4327724843 hasConcept C86803240 @default.
• W4327724843 hasConceptScore W4327724843C120665830 @default.
• W4327724843 hasConceptScore W4327724843C121332964 @default.
• W4327724843 hasConceptScore W4327724843C126322002 @default.
• W4327724843 hasConceptScore W4327724843C164705383 @default.
• W4327724843 hasConceptScore W4327724843C167135981 @default.
• W4327724843 hasConceptScore W4327724843C203092338 @default.
• W4327724843 hasConceptScore W4327724843C2777335384 @default.
• W4327724843 hasConceptScore W4327724843C2778198053 @default.
• W4327724843 hasConceptScore W4327724843C2778376644 @default.
• W4327724843 hasConceptScore W4327724843C2779234561 @default.
• W4327724843 hasConceptScore W4327724843C2780930700 @default.
• W4327724843 hasConceptScore W4327724843C535046627 @default.
• W4327724843 hasConceptScore W4327724843C54355233 @default.
• W4327724843 hasConceptScore W4327724843C61511704 @default.
• W4327724843 hasConceptScore W4327724843C71924100 @default.
• W4327724843 hasConceptScore W4327724843C72563966 @default.
• W4327724843 hasConceptScore W4327724843C86803240 @default.
• W4327724843 hasLocation W43277248431 @default.
• W4327724843 hasOpenAccess W4327724843 @default.
• W4327724843 hasPrimaryLocation W43277248431 @default.
• W4327724843 hasRelatedWork W1506887995 @default.
• W4327724843 hasRelatedWork W2034328030 @default.
• W4327724843 hasRelatedWork W2131842328 @default.
• W4327724843 hasRelatedWork W2272467143 @default.
• W4327724843 hasRelatedWork W2314186319 @default.
• W4327724843 hasRelatedWork W2431903762 @default.
• W4327724843 hasRelatedWork W2806921363 @default.
• W4327724843 hasRelatedWork W3043971815 @default.
• W4327724843 hasRelatedWork W76541811 @default.

• next